| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005730 | nucleolus | 5 | 2 |
| GO:0005737 | cytoplasm | 2 | 2 |
| GO:0043226 | organelle | 2 | 2 |
| GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
| GO:0043229 | intracellular organelle | 3 | 2 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q8I6
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 11 |
| GO:0005488 | binding | 1 | 11 |
| GO:0097159 | organic cyclic compound binding | 2 | 11 |
| GO:1901363 | heterocyclic compound binding | 2 | 11 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.578 |
| DOC_MAPK_gen_1 | 40 | 47 | PF00069 | 0.496 |
| DOC_MAPK_MEF2A_6 | 9 | 16 | PF00069 | 0.671 |
| DOC_PP1_RVXF_1 | 19 | 26 | PF00149 | 0.335 |
| DOC_WW_Pin1_4 | 97 | 102 | PF00397 | 0.578 |
| LIG_14-3-3_CanoR_1 | 3 | 8 | PF00244 | 0.606 |
| LIG_AP2alpha_1 | 138 | 142 | PF02296 | 0.654 |
| LIG_BRCT_BRCA1_1 | 138 | 142 | PF00533 | 0.631 |
| LIG_FHA_1 | 17 | 23 | PF00498 | 0.515 |
| LIG_FHA_2 | 75 | 81 | PF00498 | 0.482 |
| LIG_LIR_Nem_3 | 54 | 60 | PF02991 | 0.489 |
| LIG_PDZ_Class_3 | 137 | 142 | PF00595 | 0.612 |
| LIG_Pex14_2 | 138 | 142 | PF04695 | 0.654 |
| LIG_SH2_CRK | 57 | 61 | PF00017 | 0.562 |
| LIG_SH3_3 | 79 | 85 | PF00018 | 0.496 |
| LIG_SH3_3 | 88 | 94 | PF00018 | 0.586 |
| LIG_SUMO_SIM_anti_2 | 13 | 19 | PF11976 | 0.629 |
| MOD_CDK_SPxxK_3 | 97 | 104 | PF00069 | 0.581 |
| MOD_CK1_1 | 24 | 30 | PF00069 | 0.471 |
| MOD_CK1_1 | 5 | 11 | PF00069 | 0.655 |
| MOD_CK2_1 | 74 | 80 | PF00069 | 0.482 |
| MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.630 |
| MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.281 |
| MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.282 |
| MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.592 |
| MOD_GSK3_1 | 45 | 52 | PF00069 | 0.482 |
| MOD_N-GLC_1 | 136 | 141 | PF02516 | 0.666 |
| MOD_N-GLC_1 | 80 | 85 | PF02516 | 0.296 |
| MOD_NEK2_1 | 16 | 21 | PF00069 | 0.557 |
| MOD_NEK2_1 | 2 | 7 | PF00069 | 0.584 |
| MOD_PIKK_1 | 69 | 75 | PF00454 | 0.482 |
| MOD_PK_1 | 3 | 9 | PF00069 | 0.705 |
| MOD_PKA_2 | 2 | 8 | PF00069 | 0.566 |
| MOD_Plk_4 | 21 | 27 | PF00069 | 0.417 |
| MOD_ProDKin_1 | 97 | 103 | PF00069 | 0.579 |
| TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.562 |
| TRG_Pf-PMV_PEXEL_1 | 58 | 63 | PF00026 | 0.386 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PDL5 | Leptomonas seymouri | 78% | 99% |
| A0A0S4IK01 | Bodo saltans | 70% | 87% |
| A0A1X0NZ24 | Trypanosomatidae | 83% | 100% |
| A0A3S7X1B7 | Leishmania donovani | 96% | 99% |
| A0A422N385 | Trypanosoma rangeli | 84% | 100% |
| A4HGC6 | Leishmania braziliensis | 95% | 99% |
| A4I3F8 | Leishmania infantum | 97% | 99% |
| D0A7Y1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 70% | 100% |
| E9AZP7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |